{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:15:11Z","timestamp":1783329311774,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016589","name":"Tokyo Metropolitan Institute of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009667","name":"School of Medicine, Kyorin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006724","name":"The Japanese Urological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP15ck0106144"],"award-info":[{"award-number":["JP15ck0106144"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18ck0106416"],"award-info":[{"award-number":["JP18ck0106416"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19lm0203004"],"award-info":[{"award-number":["JP19lm0203004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16lm0103002"],"award-info":[{"award-number":["JP16lm0103002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201252","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:12:33Z","timestamp":1779981153000},"page":"201252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Induced pluripotent stem cell-derived dendritic cells potentiate the efficacy of interleukin-12-expressing oncolytic HSV-1"],"prefix":"10.1016","volume":"34","author":[{"given":"Satoru","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Kakutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimpei","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-8010","authenticated-orcid":false,"given":"Tomoki","family":"Todo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201252_bib1","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/cas.13027","article-title":"Oncolytic virus therapy: A new era of cancer treatment at dawn","volume":"107","author":"Fukuhara","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omton.2026.201252_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/iju.13325","article-title":"Current status of clinical trials assessing oncolytic virus therapy for urological cancers","volume":"24","author":"Taguchi","year":"2017","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.omton.2026.201252_bib3","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1073\/pnas.101136398","article-title":"Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing","volume":"98","author":"Todo","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201252_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jjco\/hyy170","article-title":"Oncolytic virus therapy in Japan: progress in clinical trials and future perspectives","volume":"49","author":"Taguchi","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201252_bib5","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41467-022-31262-y","article-title":"A phase I\/II study of triple-mutated oncolytic herpes virus G47\u0394 in patients with progressive glioblastoma","volume":"13","author":"Todo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201252_bib6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u0394 for residual or recurrent glioblastoma: a phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201252_bib7","first-page":"491","article-title":"Optimizing dendritic cell-based approaches for cancer immunotherapy","volume":"87","author":"Datta","year":"2014","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.omton.2026.201252_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/sj.onc.1210884","article-title":"Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation","volume":"27","author":"Endo","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2026.201252_bib9","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1158\/1078-0432.CCR-08-1364","article-title":"Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells","volume":"14","author":"Farrell","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201252_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/mt.2009.205","article-title":"Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL","volume":"18","author":"Huang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201252_bib11","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201252_bib12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/2326-6066.CIR-14-0117","article-title":"Generation of mouse pluripotent stem cell-derived proliferating myeloid cells as an unlimited source of functional antigen-presenting cells","volume":"3","author":"Zhang","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omton.2026.201252_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ijc.28367","article-title":"Antitumor immune response of dendritic cells (DCs) expressing tumor-associated antigens derived from induced pluripotent stem cells: in comparison to bone marrow-derived DCs","volume":"134","author":"Iwamoto","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2026.201252_bib14","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/srep03979","article-title":"Generation and characterization of regulatory dendritic cells derived from murine induced pluripotent stem cells","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201252_bib15","first-page":"40","article-title":"Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12. Commun","volume":"3","author":"Fukuhara","year":"2023","journal-title":"Med. (Lond.)"},{"key":"10.1016\/j.omton.2026.201252_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201252_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","article-title":"Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements","volume":"76","author":"Barnden","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.omton.2026.201252_bib18","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.stemcr.2017.03.020","article-title":"iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells","volume":"8","author":"Cai","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omton.2026.201252_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.omto.2021.05.004","article-title":"Oncolytic herpes virus G47\u0394 works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation","volume":"22","author":"Sugawara","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2026.201252_bib20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","article-title":"Antitumor and antimetastatic activity of interleukin 12 against murine tumors","volume":"178","author":"Brunda","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2026.201252_bib21","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4049\/jimmunol.153.4.1697","article-title":"Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production","volume":"153","author":"Nastala","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201252_bib22","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","article-title":"Interleukin-12: biological properties and clinical application","volume":"13","author":"Del Vecchio","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201252_bib23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1126\/science.270.5238.908.a","article-title":"IL-12 deaths: explanation and a puzzle","volume":"270","author":"Cohen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.omton.2026.201252_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575597","article-title":"Localized Interleukin-12 for Cancer Immunotherapy","volume":"11","author":"Nguyen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201252_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201252_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/stem.33","article-title":"Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells","volume":"27","author":"Senju","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.omton.2026.201252_bib27","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1038\/s41598-018-23120-z","article-title":"Cancer Vaccine Therapy Using Carcinoembryonic Antigen - expressing Dendritic Cells generated from Induced Pluripotent Stem Cells","volume":"8","author":"Kitadani","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201252_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002432","article-title":"In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models","volume":"9","author":"Oba","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2026.201252_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.medj.2022.10.003","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med."},{"key":"10.1016\/j.omton.2026.201252_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jrr\/rrw124","article-title":"Irradiation strongly reduces tumorigenesis of human induced pluripotent stem cells","volume":"58","author":"Inui","year":"2017","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.omton.2026.201252_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-3083.2005.01556.x","article-title":"Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions","volume":"61","author":"Wells","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.omton.2026.201252_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11807","article-title":"Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells","volume":"494","author":"Araki","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201252_bib33","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1158\/0008-5472.CAN-05-2534","article-title":"Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system","volume":"65","author":"Fukuhara","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201252_bib34","first-page":"1017","article-title":"Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro","volume":"62","author":"Summerhayes","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.omton.2026.201252_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1258\/002367705774286475","article-title":"Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy","volume":"39","author":"Loskog","year":"2005","journal-title":"Lab. Anim."},{"key":"10.1016\/j.omton.2026.201252_bib36","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.vaccine.2010.05.038","article-title":"A novel therapeutic vaccine of GM-CSF\/TNF-a surface-modified RM-1 cells against the orthotopic prostatic cancer","volume":"28","author":"Yin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.omton.2026.201252_bib37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.urolonc.2011.08.001","article-title":"Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer","volume":"31","author":"Shi","year":"2013","journal-title":"Urol. Oncol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:19:22Z","timestamp":1783325962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926001281"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201252","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induced pluripotent stem cell-derived dendritic cells potentiate the efficacy of interleukin-12-expressing oncolytic HSV-1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201252"}}